BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6805362)

  • 21. Loss of nitroglycerin during passage through two different infusion sets.
    Hansen HC; Spillum A
    Acta Pharm Nord; 1991; 3(3):131-6. PubMed ID: 1793507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of glyceryl trinitrate and of isosorbide dinitrate during infusion: a literature survey and practical recommendations.
    Remon JP; Bogaert MG
    Acta Clin Belg; 1983; 38(5):338-41. PubMed ID: 6419518
    [No Abstract]   [Full Text] [Related]  

  • 23. Current concepts of I.V. nitroglycerin therapy.
    Wagner W
    NITA; 1983; 6(5):342-4. PubMed ID: 6413909
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of models describing the sorption of nitroglycerin and diazepam by plastic infusion systems: diffusion and compartment models.
    Kowaluk EA; Roberts MS; Polack AE
    J Pharm Sci; 1985 Jun; 74(6):625-33. PubMed ID: 3926985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment on intravenous nitroglycerin.
    Robinson LA; Wright BT
    Drug Intell Clin Pharm; 1983 Jan; 17(1):49. PubMed ID: 6402349
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin adsorbance to polyvinylchloride surfaces with implications for constant-infusion therapy.
    Peterson L; Caldwell J; Hoffman J
    Diabetes; 1976 Jan; 25(1):72-4. PubMed ID: 1245268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment: nitroglycerin iv tubing adsorption.
    Mendel S; Green JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):946-7. PubMed ID: 3936690
    [No Abstract]   [Full Text] [Related]  

  • 28. [Retention of ethylene oxide after sterilization of polyvinyl chloride and polyethylene material].
    Lacomme M; Le Moan G; Chaigneau M
    Ann Pharm Fr; 1975; 33(6-7):337-44. PubMed ID: 1220602
    [No Abstract]   [Full Text] [Related]  

  • 29. [Procceedings: Polyvinylchloride disease with acroscleroderma].
    Miller W; Balda BR
    Hautarzt; 1975 Jul; 26(7):387. PubMed ID: 1213900
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serum nitroglycerin concentrations during extracorporeal circulation with a membrane oxygenator incorporated with a cardiopulmonary bypass circuit].
    Saitoh K; Ikeno S; Horiguchi Y; Fukuda H; Hirabayashi Y; Mitsuhata H; Akazawa S; Kasuda H; Shimizu R
    Masui; 1993 Dec; 42(12):1799-802. PubMed ID: 8301828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration set suitable for use with intravenous nitroglycerin.
    Baaske DM; Amann AH; Karnatz NN; Wong J; Wagenknecht DM; Carter JE; Stoll RG
    Am J Hosp Pharm; 1982 Jan; 39(1):121-2. PubMed ID: 6798867
    [No Abstract]   [Full Text] [Related]  

  • 32. Administration set purging for dosage adjustments in intravenous nitroglycerin therapy.
    Raymond GG; Day PL
    NITA; 1983; 6(6):415-6. PubMed ID: 6417575
    [No Abstract]   [Full Text] [Related]  

  • 33. Volumetric pump cassette modification for intravenous nitroglycerin delivery.
    Pendleton KC; Wellman GS
    Am J Hosp Pharm; 1982 Jul; 39(7):1145. PubMed ID: 6810695
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug loss in polyolefin infusion systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1983 Jan; 40(1):118-9. PubMed ID: 6823983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Microorganism adsorption to polyvinyl chloride plastic materials].
    Korchak GI
    Gig Sanit; 1977 May; (5):110-1. PubMed ID: 406167
    [No Abstract]   [Full Text] [Related]  

  • 36. [Haemangiosarcomatosis after professional exposure to polyvinylchloride (author's transl)].
    Wallnöfer H; Zinnagl N
    Med Klin; 1977 Mar; 72(10):410-3. PubMed ID: 557164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. System for intravenous infusion of nitroglycerin and diazepam.
    Mathot F; Paris P; Hans P
    Am J Hosp Pharm; 1983 Jun; 40(6):948. PubMed ID: 6408921
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with intravenous infusion of nitroglycerin in myocardial infarction and acute coronary failure].
    Aleksandrow D; Aleksandrow W; Dyduszyński A; Wiernikowski A
    Kardiol Pol; 1982; 25(10-11):821-8. PubMed ID: 6820808
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems with administration devices for commercially available nitroglycerin injection.
    Am J Hosp Pharm; 1982 Mar; 39(3):400, 403-4. PubMed ID: 6803587
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of the orthopedic equipment made of plastics in children].
    Boĭko IaI; Shevchenko SD; Suvorova VV; Timchenko IB; Bezvesil'naia GV
    Ortop Travmatol Protez; 1979 Jun; (6):19-22. PubMed ID: 471449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.